Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

April 7, 2022

Study Completion Date

April 7, 2022

Conditions
Pediatric Crohn's Disease
Interventions
DRUG

Methotrexate

"1. Oral methotrexate (MTX): The weekly dose will be 15 mg for children ≥ 40kg, 12.5 mg for children 30 to \<40 kg, and 10 mg for children 20 to \<30 kg.~2. A twice per week, 4mg dose of ondansetron will be provided as pre-treatment to prevent nausea (study provider may opt-out of this component based on clinical judgement).~3. A 1 mg dose of folic acid per day will be provided. This will help to reduce the risk of side effects in the MTX group.~Drug kits will contain a 3 month supply of each medication. Refills will be provided every 3 months until week 156 unless there is a failure to induce and maintain remission, development of unacceptable toxicity, pregnancy in a female participant, or failure of the participant to attend scheduled study visits."

OTHER

Sugar pill (placebo)

"1. Placebo for methotrexate: The weekly dose will mimic that of methotrexate.~2. Placebo for ondansetron: The weekly dose will mimic that of ondansetron (study provider may opt-out of this component based on clinical judgement).~3. A 1 mg dose of folic acid per day will be provided to maintain blinding.~Drug kits will contain a 3 month supply of each medication. Refills will be provided every 3 months until week 156 unless there is a failure to induce and maintain remission, development of unacceptable toxicity, pregnancy in a female participant, or failure of the participant to attend scheduled study visits."

Trial Locations (32)

10029

Mount Sinai Kravis Children's Hospital, New York

13210

Upstate Golisano Children's Hospital, Syracuse

19803

Nemours Children's Health System - Wilmington, Wilmington

22031

Pediatric Specialists of Virginia, Fairfax

23507

Children's Hospital of The King's Daughters, Norfolk

27514

University of North Carolina at Chapel Hill, Chapel Hill

28203

Levine Children's Hospital, Charlotte

30329

Children's Healthcare of Atlanta at Egleston/Emory University, Atlanta

32207

Nemours Children's Health System - Jacksonville, Jacksonville

32827

Nemours Children's Health System - Orlando, Orlando

33155

Nicklaus Children's Hospital, Miami

35233

Children's of Alabama, Birmingham

37232

Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville

43205

Nationwide Children's Hospital, Columbus

44106

Rainbow Babies & Children's Hospital, Cleveland

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

45404

Dayton Children's Hospital, Dayton

46202

Riley Hospital for Children, Indianapolis

52242

University of Iowa Children's Hospital, Iowa City

53226

Children's Hospital of Wisconsin, Milwaukee

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

63104

Cardinal Glennon Children's Medical Center, St Louis

64108

Children's Mercy Hospital, Kansas City

68114

Children's Hospital and Medical Center Omaha, Omaha

73104

Oklahoma University Medical Center, Oklahoma City

94304

Stanford Children's Health, Alto

06510

Yale-New Haven Children's Hospital, New Haven

02114

MassGeneral Hospital for Children, Boston

02115

Boston Children's Hospital, Boston

Michigan

"University of Michigan , CS Mott Children's Hospital"

Missouri

"St. Louis Children's Hospital , Washington University"

05401

The University of Vermont Children's Hospital, Burlington

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

ImproveCareNow (ICN)

OTHER

collaborator

The Leona M. and Harry B. Helmsley Charitable Trust

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Grifols Diagnostics Solutions, Inc

UNKNOWN

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT02772965 - Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy | Biotech Hunter | Biotech Hunter